Muscle-invasive bladder cancer

被引:1
|
作者
Buchler, Jakob [1 ]
Gschwend, Juergen E. [1 ]
Retz, Margitta [1 ]
Schmid, Sebastian C. [1 ]
机构
[1] Tech Univ Munich, Univ Klinikum Rechts Isar, Klin & Poliklin Urol, Ismaninger Str 22, D-81675 Munich, Germany
来源
UROLOGE | 2021年 / 60卷 / 06期
关键词
Urinary bladder neoplasms; Transurethral resection; BCG; Cystectomy; Chemotherapy; neoadjuvant; Urinary division; BACILLUS-CALMETTE-GUERIN; TRANSURETHRAL RESECTION; RADICAL CYSTECTOMY; ILEAL CONDUIT; FLUORESCENCE CYSTOSCOPY; UROTHELIAL CARCINOMA; RECURRENCE; T1; METAANALYSIS; PROGRESSION;
D O I
10.1007/s00120-021-01536-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline "Early detection, diagnosis, treatment and aftercare of bladder cancer" are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options-ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy-are discussed on the basis of the current literature.
引用
收藏
页码:769 / 775
页数:7
相关论文
共 50 条
  • [41] Perioperative immunotherapy in muscle-invasive bladder cancer
    Lee, Hyung Ho
    Ham, Won Sik
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6546 - 6553
  • [42] The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature
    Claps, Francesco
    Biasatti, Arianna
    Di Gianfrancesco, Luca
    Ongaro, Luca
    Giannarini, Gianluca
    Pavan, Nicola
    Amodeo, Antonio
    Simonato, Alchiede
    Crestani, Alessandro
    Cimadamore, Alessia
    Hurle, Rodolfo
    Mertens, Laura S.
    van Rhijn, Bas W. G.
    Porreca, Angelo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [43] Contemporary management of muscle-invasive bladder cancer
    Dall'Era, Marc A.
    Cheng, Liang
    Pan, Chong-Xian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (07) : 941 - 950
  • [44] Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer
    Booth, Christopher M.
    Siemens, D. Robert
    Li, Gavin
    Peng, Yingwei
    Tannock, Ian F.
    Kong, Weidong
    Berman, David M.
    Mackillop, William J.
    CANCER, 2014, 120 (11) : 1630 - 1638
  • [45] Management of muscle-invasive bladder cancer: an update
    Ghoneim, Mohamed A.
    Abol-Enein, Hassan
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (09): : 501 - 508
  • [46] Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
    Supit, Wempy
    Mochtar, Chaidir Arif
    Santoso, Rachmat Budi
    Umbas, Rainy
    ASIAN JOURNAL OF SURGERY, 2014, 37 (04) : 184 - 189
  • [47] Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review
    Koukourakis, Georgios
    Kouloulias, Vassilios
    Zacharias, Georgios
    Sotiropoulou-Lontou, Anastasia
    Koukourakis, Michael
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (05) : 315 - 321
  • [48] Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool
    D' Andrea, David
    Abufaraj, Mohammad
    Susani, Martin
    Ristl, Robin
    Foerster, Beat
    Kimura, Shoji
    Mari, Andrea
    Soria, Francesco
    Briganti, Alberto
    Karakiewicz, Pierre I.
    Gust, Killian M.
    Roupret, Morgan
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) : 239.e1 - 239.e7
  • [49] Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer
    McPherson, Victor A.
    Rodrigues, George
    Bauman, Glenn
    Winquist, Eric
    Chin, Joseph
    Izawa, Jonathan
    Potvin, Kylea
    Ernst, Scott
    Venkatesan, Varagur
    Sexton, Tracy
    Ahmad, Belal
    Power, Nicholas
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (1-2): : 24 - 30
  • [50] Current management of muscle-invasive bladder cancer
    Gemma Sancho
    Pablo Maroto
    Joan Palou
    Clinical and Translational Oncology, 2011, 13 : 855 - 861